DUBLIN, Apr 5, 2017 /PRNewswire/ --
Research and Markets has announced the addition of the "China Pharmaceutical Packaging Industry Report, 2016-2021" report to their offering.
Under the impetus of the fast-growing downstream pharmaceutical industry, Chinese pharmaceutical packaging market size increased year by year at the CAGR of 11.2% during 2010-2016. From 2017 to 2021, the market size will maintain the growth rate of about 10% and is expected to outnumber RMB140 billion in 2021, thanks to severe aging, the released two-child policy, the rapid development of biological agents and supporting policies.
More than 1,500 Chinese pharmaceutical packaging enterprises are mostly small and scattered, so the market needs integrating at once. Driven by the Guidance on Speeding up Corporate Mergers and Acquisitions of Key Industries and other policies, China pharmaceutical packaging industry has witnessed frequent mergers and acquisitions in recent years, for instance, Fengyuan Pharmaceutical acquired Chengdu PUSH Pharmaceutical, China Jianyin Investment Ltd (JIC) took over SGD, Chienyeh Pharmaceutical Packaging bought Nanchong Sanying Medicinal Packaging Material Co., Ltd. In this case, the concentration of Chinese pharmaceutical packaging market has been raised progressively.
At present, Chinese high-end pharmaceutical packaging market is mainly occupied by BD, Gerresheimer, SCHOTT, Nipro, Amcor and other multinational companies, while the medium and low-end market is dominated by local firms. In recent years, higher pharmaceutical packaging standards propel local enterprises to intensify R & D, so they will gradually transfer to the high-end market in future.
Key Topics Covered:
1.3 Industry Chain
2 Chinese Pharmaceutical Packaging Industry
2.1 Status Quo
2.2 Market Size
2.3 Competitive Landscape
2.4 Import & Export
2.5 Market Segments
2.5.1 Medicinal Glass Packaging
2.5.2 Medicinal Plastic Packaging
2.5.3 Medicinal Rubber Packaging
2.5.4 Composite Packaging Materials
2.6 Downstream Demand
2.6.2 Blood Product
2.7 Development Trends
2.7.1 Population Aging and Two-child Policy Conduce to the Development of Pharmaceutical Industry
2.7.2 Favorable Policies Promote the Development of Pharmaceutical Packaging Industry
2.7.3 Rapid Development of Biological Agents is in Favor of Pharmaceutical Packaging Industry
2.7.4 Neutral Borosilicate Pharmaceutical Glass Tube Will Substitute for Low Borosilicate Products Gradually
2.7.5 New Pharmaceutical Packaging Materials Grow Up
2.7.6 Pharmaceutical Packaging Industry Concentration Gets Improved Further
3 Foreign Companies
3.1 Becton, Dickinson and Company
3.2 Gerresheimer AG
3.3 SCHOTT AG
3.4 Nipro Medical Corporation
4 Chinese Companies
4.1 Shandong Pharmaceutical Glass Co., Ltd.
4.2 Sichuan Kelun Pharmaceutical Co., Ltd.
4.3 Guizhou Chienyeh Pharmaceutical Packaging Co., Ltd.
4.4 Shandong Weigao Group Medical Polymer Co., Ltd (WEGO)
4.5 Hongguang Medicine Packaging Company
4.6 Tongyu Pharmaceutical Packaging Co., Ltd.
4.7 Linuo Glassworks Group
4.8 Shanghai Haishun New Pharmaceutical Packaging Co., Ltd.
For more information about this report visit http://www.researchandmarkets.com/research/mlzdhj/china
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/china-pharmaceutical-packaging-industry-report-2017-2021-focus-on-4-foreign-companies--8-local-companies---research-and-markets-300435402.html
SOURCE Research and Markets